Aim: To characterize the pharmacokinetics of dexmedetomidine in Chinese pediatric patients using a population pharmacokinetic ***: 39 children with an age between 1 and 9 years undergoing surgery were enrolled in the ...
详细信息
Aim: To characterize the pharmacokinetics of dexmedetomidine in Chinese pediatric patients using a population pharmacokinetic ***: 39 children with an age between 1 and 9 years undergoing surgery were enrolled in the *** was administered as short infusion in 10 *** samples were drawn until 480 min after stop of *** concentrations were measured with HPLC and ***: The pharmacokinetics of dexmedetomidine was best described a two-compartment model with an allometric power model for the effect of body *** population estimates (95% CI) for a typical child of 15 kg were CL=0.190 (0.171-0.211) L·min-1, V1=18.1 (13.6-19.4) L,Q=0.44 (0.33-0.84) L·min-1, V2=24.4 (20.6-31.1) L, and a terminal elimination half-life of 180 (147-217) ***: Chinese children showed a similar clearance but larger volumes of distribution and longer terminal half-life when compared to studies in *** allometric power model was most appropriate to describe the effect of body weight.
暂无评论